<doc>
  <docmeta id="113hr3969ih">
    <bill congress="113" type="hr" number="3969" version="ih"/>
    <revision size="11002" annotations="0" status="complete" id="6" commit-time="2014-02-03T22:02:12Z" committer="mbohmer" doc="113hr3969ih/6.xml">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="H3EBFD8A1888244B9A77EDA8440B21894" public-private="public">
  <metadata>
<dublinCore>
<dc:title xmlns:dc="http://purl.org/dc/elements/1.1/">113 HR 3969 IH: Preventing Abuse of Cough Treatments Act of 2014</dc:title>
<dc:publisher xmlns:dc="http://purl.org/dc/elements/1.1/">U.S. House of Representatives</dc:publisher>
<dc:date xmlns:dc="http://purl.org/dc/elements/1.1/">2014-01-29</dc:date>
<dc:format xmlns:dc="http://purl.org/dc/elements/1.1/">text/xml</dc:format>
<dc:language xmlns:dc="http://purl.org/dc/elements/1.1/">EN</dc:language>
<dc:rights xmlns:dc="http://purl.org/dc/elements/1.1/">Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code>
    <congress>113th CONGRESS</congress>
    <session>2d Session</session>
    <legis-num>H. R. 3969</legis-num>
    <current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber>
    <action>
      <action-date date="20140129">January 29, 2014</action-date>
      <action-desc>
        <sponsor name-id="J000292">Mr. Johnson of Ohio</sponsor> (for himself and <cosponsor name-id="B001259">Mr. Braley of Iowa</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
    </action>
    <legis-type>A BILL</legis-type>
    <official-title>To amend the Federal Food, Drug, and Cosmetic Act to prevent the abuse of dextromethorphan, and for other purposes.</official-title>
  </form>
  <legis-body id="HD9B25F7FFD1143D99422149CD2C8CB57" style="OLC">
    <section id="HC83F7A5FEE8244DF89A8F59582E2144A" section-type="section-one">
      <enum>1.</enum>
      <header>Short title</header>
      <text display-inline="no-display-inline">This Act may be cited as the <quote>
          <short-title>Preventing Abuse of Cough Treatments Act of 2014</short-title>
        </quote> or the <quote>
          <short-title>PACT Act</short-title>
        </quote>.</text>
    </section>
    <section id="H05992590505949AD9A953EF0EAE4E801">
      <enum>2.</enum>
      <header>Sales of over-the-counter drugs containing dextromethorphan</header>
      <subsection id="H41FFDDD7929341289E5FBF5423470B13">
        <enum>(a)</enum>
        <header>Prohibited act</header>
        <text display-inline="yes-display-inline">
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref value="Federal Food, Drug, and Cosmetic Act/s:301" entity-type="act">Section 301 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/331">
            <cato:entity-ref entity-type="uscode" value="usc/21/331">21 U.S.C. 331</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="HAA1B75A70912446DA01D798D3DE2CDF9" style="OLC">
          <subsection id="HE0CCFD8DD1004C2E96C6FB6FDA7B7E55">
            <enum>(ddd)</enum>
            <paragraph commented="no" display-inline="yes-display-inline" id="H714CEDD6CB0F4616B6735B6091388E22">
              <enum>(1)</enum>
              <subparagraph commented="no" display-inline="yes-display-inline" id="HB589EAF9150B4475A725FE3093787E9F">
                <enum>(A)</enum>
                <text>Except as provided in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd/sp:2" entity-type="act">subparagraph (2)</cato:entity-ref>, the sale or offering for sale of a drug containing dex­tro­me­thor­phan to an individual under 18 years of age, including any such sale using the Internet, provided the drug is not subject to <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:503/ss:b/p:1" entity-type="act">section 503(b)(1)</cato:entity-ref>.</text>
              </subparagraph>
              <subparagraph id="HC448B61D95F447F29A0CCE69F05278FB" indent="up2">
                <enum>(B)</enum>
                <text>If a person fails to request identification from an individual under 18 years of age and sells a product containing dextromethorphan to that individual, that person shall be deemed to have known that the individual was under 18 years of age, unless from the individual’s outward appearance the person making the sale would reasonably presume the individual to be 25 years of age or older.</text>
              </subparagraph>
              <subparagraph commented="no" id="H9F36608F354348828B64BB7003D965A7" indent="up2">
                <enum>(C)</enum>
                <text>It shall be an affirmative defense to an alleged violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd/p:1/sp:A" entity-type="act">clause (A)</cato:entity-ref> that the person selling a product containing dextromethorphan examined the purchaser's identification card and, based on that examination, that person reasonably concluded that the identification was valid and indicated that the purchaser was not less than 18 years of age.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="H326BB883890A43CBBAA9CFAF97DD9E2B" indent="up1">
              <enum>(2)</enum>
              <subparagraph commented="no" display-inline="yes-display-inline" id="H82547BA3C09F446DA9BB2B9AB7D08579">
                <enum>(A)</enum>
                <text>This paragraph shall not apply to any sale made pursuant to a validly issued prescription.</text>
              </subparagraph>
              <subparagraph id="H1177B77065E14F938B24978FE2D1B0BB" indent="up1">
                <enum>(B)</enum>
                <text>This paragraph shall not apply to the sale or offering for sale of a drug containing dextromethorphan to an individual under 18 years of age if such individual supplies proof at the time of such sale that such individual is actively enrolled in the military and presents a valid military identification card.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="HBB329AB7DB1240F5BEFE8CFA5C5D31D3" indent="up1">
              <enum>(3)</enum>
              <text>In this paragraph, the term <term>identification card</term> means an identification card that—</text>
              <subparagraph id="H5E2715BB431F4B828FCE5548CE290990">
                <enum>(A)</enum>
                <text>includes a photograph and the date of birth of the individual; and</text>
              </subparagraph>
              <subparagraph id="H4D1C4368D4EE42A186A30008E30F456B">
                <enum>(B)</enum>
                <text>is issued by a State or the Federal Government or is considered acceptable for purposes of sections <external-xref legal-doc="usc" parsable-cite="usc/8/274a">274a.2(b)(1)(v)(A)</external-xref> and <external-xref legal-doc="usc" parsable-cite="usc/8/274a">274a.2(b)(1)(v)(B)(1)</external-xref> of title 8, Code of Federal Regulations (as in effect on or after the date of the enactment of the <short-title>Preventing Abuse of Cough Treatments Act of 2014</short-title>).</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
      <subsection id="H581E525908D94B9A9886953C730BA307">
        <enum>(b)</enum>
        <header>Civil penalties</header>
        <text>
          <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
            <cato:entity-ref value="Federal Food, Drug, and Cosmetic Act/s:303" entity-type="act">Section 303 of the Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/333">
            <cato:entity-ref entity-type="uscode" value="usc/21/333">21 U.S.C. 333</cato:entity-ref>
          </external-xref>)</cato:entity> is amended by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="HA3A9D1D59EE24B168EDB309445E56F5C" style="OLC">
          <subsection id="HB40349836804481AB28AA1DD433D9915">
            <enum>(h)</enum>
            <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:303/ss:a" entity-type="act">subsection (a)</cato:entity-ref>, the following provisions shall apply to violations of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref>:</text>
            <paragraph id="HED5CCA8A74514E888F3E74DB8A9B9C14">
              <enum>(1)</enum>
              <text>A person who violates <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref> shall—</text>
              <subparagraph id="HB2D99E8C3AD840B997A1BE4819E6F36E">
                <enum>(A)</enum>
                <text>receive a warning letter from the Secretary for the first such violation; and</text>
              </subparagraph>
              <subparagraph id="HEA677EE93B1645C3B4D0D49EF95BA7CD">
                <enum>(B)</enum>
                <text>be subject to a civil penalty in an amount—</text>
                <clause id="HC6752FCF8F344D1E9C19713CBABDC968">
                  <enum>(i)</enum>
                  <text>not more than $1,000 for the second such violation by a person;</text>
                </clause>
                <clause id="H20E9E4B64856486F9092084847CF0EA9">
                  <enum>(ii)</enum>
                  <text>not more than $2,000 for the third such violation by a person; and</text>
                </clause>
                <clause id="HC4A96F4671C3419C808DA7A18DCD46EB">
                  <enum>(iii)</enum>
                  <text>not more than $5,000 for the fourth such violation, or a subsequent such violation, by a person.</text>
                </clause>
              </subparagraph>
            </paragraph>
            <paragraph id="H615081EA7E4947E39D4380D7BFA77B0E">
              <enum>(2)</enum>
              <text>In determining the amount of a civil penalty under this subsection for a person who is a retailer, the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall consider whether the retailer has taken appropriate steps to prevent subsequent violations, such as the establishment and administration of a documented employee training program to ensure all employees are familiar with and abiding by the provisions of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref>, where such program includes—</text>
              <subparagraph id="HCB05053B686A40C79E9A577ED416BCCF">
                <enum>(A)</enum>
                <text>educating employees regarding products containing dextromethorphan;</text>
              </subparagraph>
              <subparagraph id="HA086066F9FBF4C4D863AD4F77C132D85">
                <enum>(B)</enum>
                <text>instruction on the correct method of checking a purchaser’s identification card; and</text>
              </subparagraph>
              <subparagraph id="HE7BFBEC4A2494678A933782068BB6995">
                <enum>(C)</enum>
                <text>notifying employees of the civil penalties under this subsection.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="H7B4EC74FF57749CEADDB158031C8407A">
              <enum>(3)</enum>
              <text>If a person who is a retailer transacts sales of products containing dextromethorphan at more than one physical location, for purposes of determining the number of violations by that person under this subsection, each individual physical location operated by that retailer shall be considered a separate person.</text>
            </paragraph>
            <paragraph commented="no" id="H6FEFCE6379234060B387F0E25091B486">
              <enum>(4)</enum>
              <text>The <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> shall notify persons found to have violated <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref> as soon as practicable after the <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" entity-id="7500" entity-type="federal-body">Secretary</cato:entity-ref> discovers such violation. Such notification shall include details of the violation, such as—</text>
              <subparagraph id="H3CEFF7036F084C73AC3A342505525739">
                <enum>(A)</enum>
                <text>the date and time of the sale;</text>
              </subparagraph>
              <subparagraph id="H44804B6BA8E5406C9089479802BBC606">
                <enum>(B)</enum>
                <text>a sales receipt or credit card receipt documenting the sale; and</text>
              </subparagraph>
              <subparagraph id="H8679866DAA904C7D8C5D93D74C2B93E1">
                <enum>(C)</enum>
                <text>the name or description of the employee involved in the sale.</text>
              </subparagraph>
            </paragraph>
            <paragraph id="H9CAF7EC0DAAA470387E007AF57C2DD9A">
              <enum>(5)</enum>
              <text>Notwithstanding any other provision of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:303/ss:h" entity-type="act">this subsection</cato:entity-ref> or <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref>, an employee shall not be subject to penalties under this subsection unless such employee knowingly and willfully participates in a conspiracy to violate <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref>. For purposes of this paragraph, a conspiracy shall consist of an agreement between two or more persons with the intent to violate <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:301/ss:ddd" entity-type="act">section 301(ddd)</cato:entity-ref> and the commission of at least one overt act in furtherance of the agreement.</text>
            </paragraph>
            <paragraph id="HF3E884417FA649CFAD9911707D5C99B7">
              <enum>(6)</enum>
              <text>In <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:303/ss:h" entity-type="act">this subsection</cato:entity-ref>—</text>
              <subparagraph commented="no" display-inline="no-display-inline" id="H402294C718424C3E83B8F99C819D995B">
                <enum>(A)</enum>
                <text display-inline="yes-display-inline">the term <term>employee</term> means an individual who is employed by a retailer in a clerical or other non-managerial position; and</text>
              </subparagraph>
              <subparagraph id="HA3813815E7944B28B2755B11E95D3D33">
                <enum>(B)</enum>
                <text>the term <term>retailer</term> means a grocery store, general merchandise store, drug store, pharmacy, convenience store, or other entity or person whose activities as a distributor relating to products containing dextromethorphan are limited almost exclusively to sales for personal use, both in number of sales and volume of sales, either directly to walk-in customers or in face-to-face transactions by direct sales.</text>
              </subparagraph>
            </paragraph>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </subsection>
    </section>
    <section id="HE57EB0EFF04047F895CF2FF5B9047DE6">
      <enum>3.</enum>
      <header>Restrictions on distribution of bulk dextromethorphan</header>
      <text display-inline="no-display-inline">The <cato:entity xmlns:cato="http://namespaces.cato.org/catoxml" entity-type="law-citation">
          <cato:entity-ref value="Federal Food, Drug, and Cosmetic Act" entity-type="act">Federal Food, Drug, and Cosmetic Act</cato:entity-ref> (<external-xref legal-doc="usc" parsable-cite="usc/21/321">
          <cato:entity-ref entity-type="uscode" value="usc/21/321/etseq">21 U.S.C. 321 et seq</cato:entity-ref>.</external-xref>)</cato:entity> is amended—</text>
      <paragraph id="HED8C51EE6DA8413C9B4B6AFE18ECF648">
        <enum>(1)</enum>
        <text>in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:501" entity-type="act">section 501</cato:entity-ref>, by inserting at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="HA5B514CD700D429BAFF4E0D64CFED21F" style="OLC">
          <subsection id="H5AD99B77CEDF4C94AD08AC3D6E8BEA3A">
            <enum>(k)</enum>
            <text>If it is unfinished dextromethorphan and is possessed, received, or distributed in violation of <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:506G" entity-type="act" proposed="true">section 506G</cato:entity-ref>.</text>
          </subsection>
          <after-quoted-block>; </after-quoted-block>
        </quoted-block>
      </paragraph>
      <paragraph id="HB3C3AF3F05A644F798E9A23E1367BC97">
        <enum>(2)</enum>
        <text>by inserting after <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:506F" entity-type="act">section 506F</cato:entity-ref> the following:</text>
        <quoted-block display-inline="no-display-inline" id="H01D9E957FEAC4070BD762F90C5038053" style="OLC">
          <section id="H47D98E64FAB24540889B132B3864F6EC">
            <enum>506G.</enum>
            <header>Restrictions on the distribution of bulk dextromethorphan</header>
            <subsection id="H1AA9807011824FA79FB249404221C2C0">
              <enum>(a)</enum>
              <header>In general</header>
              <text>No person shall—</text>
              <paragraph id="H3A58694D0CF2451CAAF6B0ED728B8C4A">
                <enum>(1)</enum>
                <text>possess or receive unfinished dex­tro­me­thor­phan, unless the person is registered under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:510" entity-type="act">section 510</cato:entity-ref> or otherwise registered, licensed, or approved pursuant to Federal or State law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients; or</text>
              </paragraph>
              <paragraph id="HEAB5CC3D06854E0BA454C4F32E0958FE">
                <enum>(2)</enum>
                <text>distribute unfinished dextromethorphan to any person other than a person registered under <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:510" entity-type="act">section 510</cato:entity-ref> or otherwise registered, licensed, or approved pursuant to Federal or State law to engage in the practice of pharmacy, pharmaceutical production, or manufacture or distribution of drug ingredients.</text>
              </paragraph>
            </subsection>
            <subsection id="HC063CA7832B54FD49CED03380F239F68">
              <enum>(b)</enum>
              <header>Exception for common carriers</header>
              <text>This section does not apply to a common carrier that possesses, receives, or distributes unfinished dextromethorphan for purposes of distributing such unfinished dex­tro­me­thor­phan between persons described in <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" proposed="true" value="Federal Food, Drug, and Cosmetic Act/s:506G/ss:a" entity-type="act">subsection (a)</cato:entity-ref> as registered, licensed, or approved.</text>
            </subsection>
            <subsection id="H53F3752E532C46D48CA35E24AAD58204">
              <enum>(c)</enum>
              <header>Definitions</header>
              <text>In this section:</text>
              <paragraph id="HF2E67014FF464D7C88E51EB4FBDC78B5">
                <enum>(1)</enum>
                <text>The term <term>common carrier</term> means any person that holds itself out to the general public as a provider for hire of the transportation by water, land, or air of merchandise, whether or not the person actually operates the vessel, vehicle, or aircraft by which the transportation is provided, between a port or place and a port or place in the United States.</text>
              </paragraph>
              <paragraph id="HDA089418ABBE454F8593A1DBE2751DBB">
                <enum>(2)</enum>
                <text>The term <term>unfinished dextromethorphan</term> means dextromethorphan that is not contained in a drug that is in finished dosage form.</text>
              </paragraph>
            </subsection>
          </section>
          <after-quoted-block>; and</after-quoted-block>
        </quoted-block>
      </paragraph>
      <paragraph id="H5C09F66EF2D840B9BD18BAC48FACBE71">
        <enum>(3)</enum>
        <text>by amending <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:303" entity-type="act">section 303</cato:entity-ref>, as amended by <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Preventing Abuse of Cough Treatments Act of 2014/s:2/ss:b" entity-type="act" proposed="true">section 2(b)</cato:entity-ref>, by adding at the end the following:</text>
        <quoted-block display-inline="no-display-inline" id="H4CC8B5A173B7489696ECAF58E1AD5164" style="OLC">
          <subsection id="H4B7FAEABE6C14EC18B02FC6810AC88F6">
            <enum>(i)</enum>
            <text>Notwithstanding <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:303/ss:a" entity-type="act">subsection (a)</cato:entity-ref>, a person who violates <cato:entity-ref xmlns:cato="http://namespaces.cato.org/catoxml" value="Federal Food, Drug, and Cosmetic Act/s:506G" entity-type="act" proposed="true">section 506G</cato:entity-ref> shall be subject to a civil penalty of not more than $100,000.</text>
          </subsection>
          <after-quoted-block>.</after-quoted-block>
        </quoted-block>
      </paragraph>
    </section>
  </legis-body>
</bill>
</doc>